neuroConn devices get EU certification
The Notified Body TÜV SÜD Product service GmbH has certified the neuroConn devices THERA PRAX® NEURO PRAX® and DC-STIMULATOR
News
Brain activity predicts personalized antidepressant treatment
Results from the large multicenter randomized iSPOT-D study were published in Clinical Neurophysiology demonstrating that brain activity can assist in predicting antidepressant treatment outcome to commonly used antidepressant drugs
Read more … Brain activity predicts personalized antidepressant treatment